Global sterol analysis is challenging owing to the extreme diversity of sterol natural products, the tendency of cholesterol to dominate in abundance over all other sterols, and the structural lack of a strong chromophore or readily ionized functional group. We developed a method to overcome these challenges by using different isotope-labeled versions of the Girard P reagent (GP) as quantitative charge-tags for the LC-MS analysis of sterols including oxysterols.
In vertebrates, cholesterol is the dominating sterol. This sterol is metabolized via oxidation to oxysterols (see online Supplemental Fig. 1 , which accompanies the online version of this article at http://www.clinchem.org/ content/vol61/issue2) and subsequently to bile acids, bile alcohols, or hormonal steroids (1 ) . Every cell has the capacity to synthesize cholesterol, and many also have the ability to metabolize it through sterol hydroxylases and subsequently other enzymes. Numerous enzymes are involved in cholesterol metabolism, many of which accept multiple substrates with the consequent production of a diverse array of products, essentially all of which can be found in the circulation.
Oxysterols are oxygenated forms of cholesterol or its precursors. Oxysterols are not just metabolic intermediates, but also represent transport forms of cholesterol, e.g., 24S-hydroxycholesterol (24S-HC) 8 from brain to liver (2 ) . They are biologically active as ligands to nuclear receptors, e.g., 24S,25-epoxycholesterol (24S,25-EC) toward the liver X receptors (3, 4 ) , and they are involved in the immune response, e.g., 6 ) and 7␣,25-diHC (7 ) . The diverse biological properties of oxysterols make them important molecules to analyze in blood.
The importance of oxysterols has encouraged the development of analytical methods to allow their detection and quantification in biological samples. Mass spectrometry (MS) has proved an effective method for oxysterol analysis when linked to either gas chromatography (GC) or liquid chromatography (LC) (8 -12 ) . The gold standard method for quantification of oxysterols is isotope-dilution mass spectrometry; this is optimally performed with a stable isotope-labeled standard for each analyte. Whereas this is a realistic proposition for targeted analysis, it becomes impractical for global approaches.
Earlier studies (13) (14) (15) (16) (17) adopted an LC-MS approach to oxysterol analysis, but combined the approach with chemical derivatization to enhance analytical sensitivity. In the work described here, we introduce novel isotope labels into our derivatives to improve the imprecision of quantitative work. We developed 2 types of isotope-labeled derivatives: differential mass tags and isobaric mass tags. Both of these mass tags are positively charged, enhancing greatly the analytical sensitivity of the method. Here, we illustrate the use of these quantitative charge-tags for the analysis of free oxysterols and sterols present in plasma. We used quantitative charge tags to fully characterize the oxysterol profile of plasma in a single analysis, diagnose inborn errors of oxysterol metabolism and cholesterol biosynthesis, and measure the export of oxysterols from brain.
Materials and Methods

CHARGE-TAG DESIGN
The design of our quantitative charge-tags is based on the Girard P reagent (GP) (Fig. 1A, i) (Fig. 1A,  vi) . These quantitative charge-tags fall into 2 categories: (a) differential mass tags [(i) against (ii), (iii) against (v), or (iv) against (vi)]; and (b) isobaric mass tags [(iii) against (iv) and (v) against (vi)]. Differential mass tags can be used as derivatization agents to quantify one sample against another by exploiting their differing mass (⌬5 Da) but otherwise essentially identical physical and chemical properties, i.e., LC retention time and MS response (Fig. 1B) . In contrast, incorporation of isobaric mass tags by derivatization adds essentially the same mass to the substrate molecules. In this case, tagged samples can be differentiated from one another following MS fragmentation, i.e., tandem mass spectrometry (MS n 
SYNTHESIS OF GIRARD REAGENTS
We synthesized the isotopically labeled Girard reagents essentially as previously described (18 ) . Full details are given in the online Supplemental Methods file.
EXTRACTION OF STEROLS AND OXYSTEROLS FROM PLASMA
We extracted sterols/oxysterols from 100 L plasma into ethanol containing deuterated internal standards. We separated oxysterols from nonpolar sterols by passing the diluted extract through a C 18 SPE cartridge (14 ) . Full details are given in the online Supplemental Methods file.
CHARGE-TAGGING OF STEROLS AND OXYSTEROLS
FROM PLASMA
The sterol and oxysterol fractions from above were reconstituted in 100 L propan-2-ol then treated with 1 mL of 50 mmol/L KH 2 PO 4 buffer (pH 7) with (FrA, ϩCHO) or without (FrB, ϪCHO) 3 L cholesterol oxidase (2 g/L in H 2 O, 44 U/mg protein). The reaction mixture was incubated at 37°C for 1 h then quenched with methanol (2.0 mL). We added glacial acetic acid (150 L) followed by GP (190 mg bromide salt or 150 mg chloride salt, 0.80 mmol). The mixture was vortex-mixed then incubated at room temperature overnight in the dark. To remove excess reagent from the reaction mixture, we carried out a second SPE step. To ensure recovery of all sterols/oxysterols of interest, we used a recycling method in which the concentration of methanol was reduced for each passage through the column, before final elution of analytes of interest with 100% methanol. The procedure is described in detail in the online Supplemental Methods file.
LC-MS(MS n ) ON THE LTQ-ORBITRAP
To analyze GP-tagged oxysterols, we diluted the methanol eluate from above to give a final solution of 60% methanol. For each experiment, 20 L (equivalent to 0.3 L plasma) was injected onto the LC column, and MS, MS 2 , and MS 3 spectra were recorded.
LC was performed on an Ultimate 3000 HPLC system (Dionex) with a Hypersil Gold reversed-phase column (1.9 m particle size, 50 ϫ 2.1 mm, Thermo Fisher) as described in the online Supplemental Methods file. The flow rate was 200 L/min, and the eluent was directed to the atmospheric pressure ionization (API) source of an LTQ-Orbitrap Velos. 
Results and Discussion
SYNTHESIS OF QUANTITATIVE CHARGE-TAGS
The isotope-labeled quantitative charge-tags were synthesized in high yields (97%). The use of [ 2 H 5 ]pyridine of Ͼ99.9% isotopic purity, the high isotopic purity of the resulting product, (ii), with respect to deuterium, in addition to the stability of deuterium on the aromatic ring with respect to H/D exchange, are major advantages of this charge-tag. We used ethyl [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] 1B) . Standard curves were plotted for endogenous oxysterols across the range of plasma volume ratios from 1:10 to 10:1. In all cases, the relationship was linear, with R 2 Ͼ 0.99 and mean deviation from the expected ratio of mean (SD) 9.1% (7.6%) (see online Supplemental Fig. 2) . Similar experiments were performed with isobaric mass tags over the same concentration range with both the SRM-like MS 2 [M]
3 total ion chromatograms (TICs) (Fig. 1C) . Again, standard curves were plotted with R 2 Ͼ 0.99 and deviation from the expected ratio of 4.7% (3.8%) and 4.9% (3.6%), respectively (see online Supplemental Figs. 3 and 4) . Differential mass tags were also evaluated on a quadrupole time-of-flight instrument in the absence of chromatographic separation for selected reference standard compounds and found to give R 2 Ͼ 0.99 and mean ratio values within 10% of expected (see online Supplemental Data Fig. 5 ).
CALIBRATION CURVES AND RECOVERY EXPERIMENTS
Ten-point calibration curves were plotted for side-chain oxidized oxysterols (24S-HC, 25-HC, and 26-HC) and B-ring oxidized oxysterols [7␣-HC, 7␤-HC, and 7-oxocholesterol (7O-C)] from 1 to 500 ng/mL. Note that we abbreviate hydroxycholesterol to HC and dihydroxycholesterol to diHC and have adopted the systematic nomenclature where 25(R)26-hydroxycholesterol is abbreviated to . Linear relationships were observed for all analytes (R 2 Ն 0.99) with the exception of 7O-C (R 2 ϭ 0.95). A 6-point calibration curve for cholesterol in the range of 0.1 to 2.5 g/L also gave satisfactory results (R 2 Ͼ 0.99). Note that these concentrations, and those of oxysterols above, refer to solutions before sample workup.
We performed recovery experiments by adding known amounts of oxysterol to a plasma sample (NIST Standard Reference Material 1950). Standard additions of 5 concentrations from 1 to 20 ng/mL were carried out, with recoveries ranging from 85% to 108% for 24S-HC, 25-HC, 26-HC, and 7␣-HC (see online Supplemental Table 2 ). Inconsistent results were obtained for 7␤-HC and 7O-C, presumably because these oxysterols are autoxidation products of cholesterol generated in part during sample preparation.
To assess the reproducibility of the method, we analyzed 3 different pooled plasma samples showing different concentrations of oxysterols multiple times to calculate intra-and interbatch CVs. For sterols other than B-ring oxidized oxysterols, intrabatch CVs were Ͻ10%, whereas interbatch CVs were Ͻ15% (see online Supplemental Table 3) .
For oxysterol analysis, although 100 L of plasma was worked up, the equivalent of only 0.3 L was injected on column. This led to a limit of detection for oxysterols in plasma of 0.05 ng/mL (3:1 signal to noise) and a limit of quantification of 0.2 ng/mL (10:1 signal to noise).
APPLICATION OF QUANTITATIVE CHARGE-TAGS
Simultaneous quantification of oxysterols with a 3-oxo or 3␤-hydroxy group. Most oxysterols have a 3␤-hydroxy or a 3-oxo group. The 3␤-hydroxy group is oxidized in vitro to a 3-oxo group by the cholesterol oxidase enzyme from Streptomyces sp. with double bond migration from C-5-C-6 to C-4 -C-5, then derivatized with GP hydrazine to enhance MS performance. We were able to use quantitative charge-tags to differentiate between molecules naturally possessing a 3-oxo group from those oxidized by cholesterol oxidase to contain a 3-oxo function ( Fig. 2A) .
This allowed the profiling of essentially all known oxysterols with a 3-oxo or 3␤-hydroxy group in a single analysis (see online Supplemental Table 1 ).
Two identical aliquots of plasma were worked up in parallel, with (A) and without (B) enzymatic oxidation, and each derivatized with a different quantitative charge- Table 1 ), both of which were present at appreciable concentrations in plasma.
Characterization of inborn errors of metabolism.
Oxysterol 7␣-hydroxylase deficiency (O7AHD), a consequence of mutations in CYP7B1 (cytochrome P450, family 7, subfamily B, polypeptide 1) 9 (20 ) , can present as cholestasis in infancy and as hereditary spastic paraplegias in adulthood. With quantitative charge-tags, we were able to readily diagnose this disease using differential mass tags to compare control and patient plasma (Fig. 3A) . Fig. 3 Fig. 6 shows chromatograms of a control plasma sample normalized to the most intense peak in each chromatogram. There was a major increase in the concentrations of 25-HC (7.12 min) (Fig. 3B) , 26-HC (7.47 min) (Fig. 3, B and C) , and 3␤-HCA (7.16 min) (Fig. 3, D and E) in patient plasma. This was not surprising, since these are substrates of the deficient enzyme. Conversely, there was a decrease in the concentrations of 3␤,7␣-diHCA/ 7␣H,3O-CA, which are products of the deficient CYP7B1 enzyme, in patient plasma (5.27 and 6.10 min, syn and anti conformers as a consequence of derivatization) (Fig. 3, F and G) . The residual presence of these 2 acids in the patient plasma is a consequence of a second pathway for their formation involving CYP7A1 rather than CYP7B1. Thus, a simple LC-MS run generates sufficient data to diagnose O7AHD. By analyzing the patient sample in the same LC-MS run as the control, any variation in chromatographic or MS response between samples is eliminated. To obtain full quantitative data, the patient sample was analyzed as A and B samples with and without enzymatic oxidation as described above (see online Supplemental Table 1 ) (21, 22 ) or as part of a quadraplex as described below.
Cerebrotendinous xanthomatosis (CTX), like O7AHD, can present in early infancy as cholestatic liver disease and in adult life with upper motor neuron signs (20 ) . CTX is a consequence of mutations in the CYP27A1 gene. CTX is a slowly progressing disease not usually diagnosed until adolescent or adult life with the appearance of xanthomas and dementia. However, it can easily be diagnosed with quantitative charge-tags by the absence of peaks corresponding to 26-HC and 3␤-HCA in the appropriate RICs. Diagnosis is confirmed by high concentrations of 7␣-HC/7␣-HCO and 7␣,12␣-diHC/ 7␣,12␣-diHCO. The application of differential mass tags is illustrated in online Supplemental Fig. 7 , and the application of isobaric mass tags (Fig. 1C) is shown in . It should be pointed out that CTX can also be diagnosed from the oxysterol pattern in plasma measured by GC-MS following appropriate derivatization or by the pattern of bile alcohol glucuronides in urine determined by negative-ion electrospray ionization MS in the absence of derivatization (10, 20 ) .
Smith-Lemli-Opitz syndrome (SLOS) is a genetic defect of cholesterol biosynthesis. The defective enzyme is 7-dehydrocholesterol reductase (DHCR7), which reduces 7-dehydrocholesterol (7-DHC) to cholesterol (23 ) . In plasma from control populations, the concentration of 7-DHC and its isomer 8-DHC is usually 2-3 orders of magnitude lower than that of cholesterol, whereas in SLOS patients its concentration is increased depending on the severity of disease (13 ) . This is illustrated by use of differential mass tags by the LC-MS RICs for patient and control plasma derivatized with [ Fig. 8, A and B) .
It is possible to combine disease diagnosis with a complete profiling of all oxysterols (or sterols) possessing Quantitative Charge-Tags for Sterol and Oxysterol Analysis either a 3␤-hydroxy or a 3-oxo group in a single LC-MS experiment by coalescing both differential mass tags and isobaric mass tags in a quadraplex of tags (Fig. 5A) . Diagnosis of a patient with SLOS was initially performed by use of duplex differential mass tags as described above (see online Supplemental Fig. 8) ; however, the patient, an infant, was also found to be suffering from Williams syndrome (caused by a deletion of genes on chromosome 7 (24 ) ). Thus, to achieve a complete oxysterol/sterol profile, plasma was derivatized with [ TICs (or MS 2 SRM-like RICs, data not shown) distinguished those oxysterols naturally possessing a 3-oxo group from those derivatized to incorporate a 3-oxo group (e.g., Fig. 5D control, Fig. 5E patient, lower panels 3O-CA, upper panels 3␤-HCA/3O-CA). Because the enzyme HSD3B7 (hydroxy-␦-5-steroid dehydrogenase, 3␤-and steroid ␦-isomerase 7) that converts oxysterols with a 3␤-hydroxy-5-ene group to the corresponding 3-oxo-4-ene requires the presence of a 7␣-hydroxy group, 3O-CA is not a product of HSD3B7-catalyzed oxidation of 3␤-HCA and is observed only at low concentrations in healthy human samples. However, as shown in Fig. 5E , substantial amounts of both 3␤-HCA and 3O-CA (lower panel) were observed in the patient sample, whereas the control sample essentially contained only 3␤-HCA (Fig. 5D ). The oxysterol profile of patients suffering from Williams syndrome has not been described previously, although it has been suggested that hypercalcemia seen in Williams syndrome patients involves altered vitamin D metabolism (25 ) . Therefore, it is unclear whether this unusual hydroxysteroid dehydrogenase activity is a consequence of the single syndrome or a combination of the 2 syndromes. Online Supplemental Table 1 summarizes data for all the oxysterols and cholestenoic acids detected in the plasma sample from the patient with SLOS and Williams syndrome. Again, it should be noted that SLOS can be diagnosed by GC-MS analysis of plasma, in which the 7-DHC (plus 8-DHC) to cholesterol ratio is increased (23 Fig. 9 for schematic) . In parallel, plasma from a peripheral vein in the arm was derivatized with [ 13 C 15 N]GP (iv) and [ 13 C 2 ]GP (iii) with and without cholesterol oxidase treatment. After LC-MS n analysis of the combined samples, the difference between the concentrations of oxysterols in the 2 veins could be used to determine the flux of oxysterols out of the brain. As shown in Fig. 6A , the concentration of diHC/diHCO was higher in the jugular vein (Fig. 6A, upper panel) than in the periphery (Fig. 6A, lower panel) . Deconvolution by MS 3 TICs showed that the concentrations of 7␣,25-diHC were comparable in the jugular vein and the periphery (0.54 and 0.34 ng/mL, respectively). The situation was similar for 7␣,26-diHC, with concentrations of 1.08 and 1.13 ng/mL, respectively. However, 7␣,25-dihydroxycholest-4-en-3-one (7␣,25-diHCO) was present at a higher concentration in the jugular vein compared to the periphery (2.09 and 0.67 ng/mL, respectively) (compare lower panels of Fig. 6D with 6C ) with a similar difference for 7␣,26-diHCO (6.91 and 2.28 ng/mL, respectively). Subsequently, when samples from 18 subjects were analyzed individually with the duplex [ 2 H 5 ]GP (ii) and [ 2 H 0 ]GP (i) (Fig. 2A) , the concentrations of 7␣,25-diHCO and 7␣,26-diHCO in the jugular vein were found to be significantly higher than the concentrations in the periphery (P Ͻ 0.001). Assuming a blood flow rate of 450 mL/min through the circulation, this corresponded to a flux out of the brain for 7␣,25-diHCO of 0.36 mg/24 h and for 7␣,26-diHCO of 1.0 mg/24 h. For comparison, the export of 24-HC and 7␣H,3O-CA from the brain has been reported to occur at rate of 4 and 2 mg/24 h, respectively (26, 27 ) .
SUMMARY
Although the concept of charge-tagging is not new (15, 28 ) , and neither is that of isotope-labeled tags (29, 30 ) , their combination for sterol analysis is. Here we have demonstrated how charge-tagging with isotope-labeled tags greatly simplifies the challenge of profiling oxysterols in plasma for disease diagnosis. The methodology should be extendable to other body fluids or tissues (22 
